Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sight Sciences (SGHT) Gains from Investment Securities (2020 - 2025)

Sight Sciences (SGHT) has 6 years of Gains from Investment Securities data on record, last reported at $763751.0 in Q4 2025.

  • For Q4 2025, Gains from Investment Securities fell 11.71% year-over-year to $763751.0; the TTM value through Dec 2025 reached $763751.0, up 25.41%, while the annual FY2025 figure was $763751.0, 82.89% down from the prior year.
  • Gains from Investment Securities reached $763751.0 in Q4 2025 per SGHT's latest filing, up from $100000.0 in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $6.7 million in Q4 2021 and bottomed at -$4.7 million in Q3 2021.
  • Average Gains from Investment Securities over 5 years is $776235.2, with a median of $128277.0 recorded in 2024.
  • Peak YoY movement for Gains from Investment Securities: plummeted 4105.41% in 2021, then skyrocketed 35338.31% in 2025.
  • A 5-year view of Gains from Investment Securities shows it stood at $6.7 million in 2021, then tumbled by 100.45% to -$30000.0 in 2022, then crashed by 1380.0% to -$444000.0 in 2023, then surged by 294.82% to $865000.0 in 2024, then dropped by 11.71% to $763751.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Gains from Investment Securities were $763751.0 in Q4 2025, $100000.0 in Q2 2025, and $4.2 million in Q1 2025.